Metformin Use and Kidney Cancer Survival Outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metformin Use and Kidney Cancer Survival Outcomes

Published:2019-03 Issue:3 Volume:42 Page:275-284
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Nayan Madhur,Punjani Nahid,Juurlink David N.,Finelli Antonio,Austin Peter C.,Kulkarni Girish S.,Uleryk Elizabeth,Hamilton Robert J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference40 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Epidemiology and risk factors for kidney cancer;Chow;Nat Rev Urol,2010

3. Rising incidence of small renal masses: a need to reassess treatment effect;Hollingsworth;J Natl Cancer Inst,2006

4. The impact of diabetes mellitus on renal cell carcinoma prognosis: a meta-analysis of cohort studies;Chen;Medicine,2015

5. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants;Danaei;Lancet,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obesity and main urologic cancers: Current systematic evidence, novel biological mechanisms, perspectives and challenges;Seminars in Cancer Biology;2023-06

2. Efficacy of metformin therapy in patients with cancer: a meta-analysis of 22 randomised controlled trials;BMC Medicine;2022-10-24

3. Correlation of miRNA-21 and blood Cr levels with tumor infiltration and distant metastasis in renal cancer patients;Cellular and Molecular Biology;2022-05-31

4. The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis;BioMed Research International;2021-10-08

5. Is metformin a geroprotector? A peek into the current clinical and experimental data;Mechanisms of Ageing and Development;2020-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3